38 results

ESPGHAN Hepatology Advice Guides

BSPGHAN Guidelines

Friday, 04 October 2019

BAPEN-BSG Guidance on Intestinal Failure

Friday, 13 September 2019

The recommendations have all been written by the named authors and revised by the BIFA committee and BAPEN council.

Latest NHS briefing on best value biologicals: adalimumab update 6

Monday, 29 July 2019

The briefing also includes information on the citrate content of biosimilars, feedback from patients and clinicians on the patient experience, and reference pricing.

Implementation of an endoscopy safety checklist

Monday, 15 July 2019

Patient safety and quality improvement are increasingly prioritised across all areas of healthcare.

AGIP Best Practice Statement for HMBT

Tuesday, 11 June 2019

AGIP encourage the use of these standards within clinical research in order to provide objective evidence of the clinical utility of HMBT.

NHS Commissioning briefing for implementation of best value adalimumab products - December 2018

Tuesday, 11 December 2018

The December RMOC paper on adalimumab is now available.

Alcohol care teams: reducing acute hospital admissions and improving quality of care

Tuesday, 20 November 2018

Alcohol-Related Disease: Meeting the challenge of improved quality of care and better use of resources

Tuesday, 20 November 2018

Recently, much attention has focused on social policy and measures to reduce drinking.

UK consensus on non-medical staffing required to deliver safe, quality-assured care for adult patients undergoing gastrointestinal endoscopy

Thursday, 10 May 2018

Dunkley I, et al. Frontline Gastroenterology 2018;0:1–11. doi:10.1136/flgastro-2017-100950

Cancer datasets and tissue pathways

Friday, 06 April 2018

The Royal College of Pathologists

Caution about the use of ulipristal acetate (Esmya)

Thursday, 05 April 2018

Esmya is indicated for the pre-operative and intermittent treatment of moderate to severe symptoms of uterine fibroids in women of reproductive age. However, following reports of serious liver injury, the European Medicines Agency (EMA), and the Medicines and Healthcare products Regulatory Agency (MHRA) have issued the following advice.

NICE Guidance: Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C

Wednesday, 21 February 2018

TA507

BSG guidance on vaccination against MAP in humans

Tuesday, 21 November 2017

BSG guidance on the use of faecal calprotectin testing in IBD

Tuesday, 21 November 2017

Guidance for Endoscopic Ultrasonography - UK EUS Users' Groups

Tuesday, 21 November 2017

Endoscopy Global Rating Scale

Tuesday, 21 November 2017

Guidance on Decontamination of Equipment for Gastrointestinal Endoscopy: 2017 Edition

Thursday, 16 November 2017

BSG guidance on the use of intravenous hyoscine butylbromide (buscopan) during gastrointestinal endoscopy

Tuesday, 04 April 2017

NICE guidance on molecular testing strategies for Lynch syndrome in people with colorectal cancer

Wednesday, 01 February 2017

Loading more...